David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 28,711 shares at $31.30 ($887K) on 2021-10-05, disclosed to the SEC on 2021-10-06.
Open-market sale of $887k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.26 | 5,908 | $179K | 20.1% |
| 2 | $30.26 | 5,908 | $179K | 20.1% |
| 3 | $31.30 | 7,803 | $244K | 27.5% |
| 4 | $31.30 | 7,803 | $244K | 27.5% |
| 5 | $32.06 | 1,289 | $41K | 4.7% |
| Total | $30.91 avg | 28,711 |
| $887K |
| 100% |
| Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |
| PRLD | SELL | 2021-05-10 | $1.2M | — | Filing → |